Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial.
C R A SilveiraJ MacKinleyK ColemanZ LiE FingerR BarthaS A MorrowJ WellsM BorrieR G TironaC A RuparG ZouR A HegeleD MahuranP MacDonaldM E JenkinsM JogStephen H PasternakPublished in: BMC neurology (2019)
ClinicalTrials.gov NCT02914366, 26 Sep 2016/retrospectively registered.